Rejuran and DoubleTite, two technologies listed on the Australian Register of Therapeutic Goods (ARTG) for use by health professionals, are the focus of an upcoming online educational event hosted by K Bridge Medical and Beauty Technology (BT).

The session will feature Dr Nark-Kyoung Rho, Rejuran Global KOL and Chief Director of Leaders Dermatology Clinic in Seoul, South Korea. Dr Rho will share current clinical perspectives on the use of DoubleTite and Rejuran, including procedural integration and practical considerations for aesthetic medical practice.

This one-hour webinar is designed for registered healthcare professionals and will provide an overview of:

• DoubleTite’s use in non-invasive clinical procedures
• Current clinical applications of Rejuran in aesthetic protocols and patient care
• Practical considerations for using these modalities in clinical workflows

REGISTER NOW

Agenda / Programme Schedule

7:00 – 7:45 PM
Presentation / Dr Nark-Kyoung Rho (Rejuran Global KOL)
Overview of DoubleTite, Rejuran, and combination protocols

7:45 – 7:55 PM
Q&A / Dr Nark-Kyoung Rho
Addresses questions raised during the event

About Dr Nark-Kyoung Rho

• Rejuran Global KOL
• Chief Director, Leaders Dermatology Clinic – Cheongdam Dosan-daero Branch, Seoul
• Board-certified Dermatologist (M.D., Seoul National University)
• Residency in Dermatology, Samsung Medical Center
• Visiting Professor, Department of Dermatology, Samsung Medical Center
• Former Head of Dermatology, Armed Forces Capital Hospital

• Member of the Korean Dermatological Association Faculty of Korean Society for Dermatologic Surgery and Korean Anti-aging Dermatology Society

Important Information

• For registered healthcare professionals only.
• Content is provided for educational purposes and should not replace individual clinical judgment.
• Rejuran and DoubleTite are ARTG-listed for use by health professionals and are not available for purchase by the general public.
• This educational session is not intended to promote or encourage the use of any therapeutic goods outside of their approved indications or scope.
• This webinar does not constitute advertising to consumers as defined under the Therapeutic Goods Act 1989.

For product specifications, professional support materials, or usage guidance, please contact:

K Bridge Medical
Exclusive Distributor for Rejuran® – Australia & New Zealand
info@kbridge.com.au
www.rejuran.com.au

Beauty Technology
Exclusive Distributor for DoubleTite
info@beautytechnology.com.au
www.beautytechnology.com.au